EcoDrugPlus

Complement C1s

Ensembl ID : ENSMMMG00000016640
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Complement C5-Like

Ensembl ID : ENSMMMG00000019210
Gene Symbol: LOC107152134
2 Cross references
199 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSMMMG00000012034
Gene Symbol: CFD
2 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMMMG00000020705
Gene Symbol: CRHR1
3 Cross references
240 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSMMMG00000005249
Gene Symbol: CDK1
3 Cross references
227 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSMMMG00000014134
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSMMMG00000010571
Gene Symbol: CDK4
3 Cross references
210 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSMMMG00000006082
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSMMMG00000020641
Gene Symbol: CDK6
3 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSMMMG00000023240
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSMMMG00000017207
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMMMG00000024296
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).